Proton-Based Stereotactic Ablative Radiotherapy in Early-Stage Non-Small-Cell Lung Cancer
暂无分享,去创建一个
[1] Joe Y. Chang,et al. Toxicity and patterns of failure of adaptive/ablative proton therapy for early-stage, medically inoperable non-small cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[2] Radhe Mohan,et al. Evaluating proton stereotactic body radiotherapy to reduce chest wall dose in the treatment of lung cancer. , 2013, Medical Dosimetry.
[3] Martin Stuschke,et al. Potentials of robust intensity modulated scanning proton plans for locally advanced lung cancer in comparison to intensity modulated photon plans. , 2012, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[4] T. Hashimoto,et al. Hypofractionated high-dose proton beam therapy for stage I non-small-cell lung cancer: preliminary results of a phase I/II clinical study. , 2007, International journal of radiation oncology, biology, physics.
[5] H. Menzel,et al. The International Commission on Radiation Units and Measurements , 2011, Journal of the ICRU.
[6] Joao Seco,et al. Proton arc reduces range uncertainty effects and improves conformality compared with photon volumetric modulated arc therapy in stereotactic body radiation therapy for non-small cell lung cancer. , 2013, International journal of radiation oncology, biology, physics.
[7] Samuel Ryu,et al. American Society for Therapeutic Radiology and Oncology (ASTRO) and American College of Radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy. , 2004, International journal of radiation oncology, biology, physics.
[8] Zuofeng Li,et al. Double-scattered proton-based stereotactic body radiotherapy for stage I lung cancer: a dosimetric comparison with photon-based stereotactic body radiotherapy. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[9] Takuya Tomoda,et al. Dose-volume comparison of proton radiotherapy and stereotactic body radiotherapy for non-small-cell lung cancer. , 2010, International journal of radiation oncology, biology, physics.
[10] Hong Ye,et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Slater,et al. High-dose hypofractionated proton beam radiation therapy is safe and effective for central and peripheral early-stage non-small cell lung cancer: results of a 12-year experience at Loma Linda University Medical Center. , 2013, International journal of radiation oncology, biology, physics.
[12] James Shackleford,et al. Motion interplay as a function of patient parameters and spot size in spot scanning proton therapy for lung cancer. , 2013, International journal of radiation oncology, biology, physics.
[13] J. Baulch,et al. The Effect of Radiation Quality on Genomic DNA Methylation Profiles in Irradiated Human Cell Lines , 2011, Radiation research.
[14] R. Pötter,et al. Can protons improve SBRT for lung lesions? Dosimetric considerations. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[15] Alfons G H Kessels,et al. Comparison of the effectiveness of radiotherapy with photons, protons and carbon-ions for non-small cell lung cancer: a meta-analysis. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[16] Joe Y. Chang,et al. Predicting radiation pneumonitis after stereotactic ablative radiation therapy in patients previously treated with conventional thoracic radiation therapy. , 2012, International journal of radiation oncology, biology, physics.
[17] R. Ferrand,et al. Calibration of CT Hounsfield units for proton therapy treatment planning: use of kilovoltage and megavoltage images and comparison of parameterized methods , 2013, Physics in medicine and biology.
[18] Yuta Shibamoto,et al. High‐dose proton therapy and carbon‐ion therapy for stage I nonsmall cell lung cancer , 2010, Cancer.
[19] Hiroki Shirato,et al. STEREOTACTIC RADIATION THERAPY WORKSHOP Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study , 2007 .
[20] Heng Li,et al. Clinical implementation of intensity modulated proton therapy for thoracic malignancies. , 2014, International journal of radiation oncology, biology, physics.
[21] M. G. Sabini,et al. Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy , 2006, Apoptosis.
[22] Joe Y. Chang,et al. Clinical controversies: proton therapy for thoracic tumors. , 2013, Seminars in radiation oncology.
[23] J. Fike,et al. Efficient Production of Reactive Oxygen Species in Neural Precursor Cells after Exposure to 250 MeV Protons , 2005, Radiation research.
[24] M. Schwarz,et al. Proton therapy in lung cancer: clinical outcomes and technical issues. A systematic review. , 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[25] T. Delaney,et al. Prescribing, Recording, and Reporting Proton-Beam Therapy , 2009 .
[26] K. Nihei,et al. High-dose proton beam therapy for Stage I non-small-cell lung cancer. , 2006, International journal of radiation oncology, biology, physics.
[27] C. Wambi,et al. Gamma-radiation (GR) triggers a unique gene expression profile associated with cell death compared to proton radiation (PR) in mice in vivo , 2008, Cancer biology & therapy.
[28] T. Paz-Elizur,et al. Evaluation of lesion clustering in irradiated plasmid DNA , 2005, International journal of radiation biology.
[29] Radhe Mohan,et al. Robust optimization of intensity modulated proton therapy. , 2012, Medical physics.
[30] K. Westover,et al. Proton SBRT for Medically Inoperable Stage I NSCLC , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[31] T. Araki,et al. Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma , 2004, Cancer.
[32] T. Sakae,et al. Induction of in situ DNA double-strand breaks and apoptosis by 200 MeV protons and 10 MV X-rays in human tumour cell lines , 2011, International journal of radiation biology.
[33] Heng Li,et al. On the interplay effects with proton scanning beams in stage III lung cancer. , 2014, Medical physics.
[34] Shinji Sugahara,et al. Proton beam therapy for patients with medically inoperable stage I non-small-cell lung cancer at the university of tsukuba. , 2010, International journal of radiation oncology, biology, physics.
[35] Radhe Mohan,et al. Proton stereotactic body radiation therapy for clinically challenging cases of centrally and superiorly located stage I non-small-cell lung cancer. , 2011, International journal of radiation oncology, biology, physics.
[36] H. Sadrozinski,et al. Development of a Head Scanner for Proton CT. , 2013, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment.
[37] Josef Korinek,et al. Proceedings of the American Society of Clinical Oncology , 1982 .
[38] Joao Seco,et al. Treatment of non-small cell lung cancer patients with proton beam-based stereotactic body radiotherapy: dosimetric comparison with photon plans highlights importance of range uncertainty. , 2012, International journal of radiation oncology, biology, physics.
[39] D. Gridley,et al. Expression of Genes Involved in Mouse Lung Cell Differentiation/Regulation after Acute Exposure to Photons and Protons with or without Low-Dose Preirradiation , 2011, Radiation research.
[40] H. Iwata,et al. A retrospective comparison of proton therapy and carbon ion therapy for stage I non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[41] Lei Dong,et al. Physics controversies in proton therapy. , 2013, Seminars in radiation oncology.
[42] A. Lomax,et al. Intensity modulated proton therapy and its sensitivity to treatment uncertainties 1: the potential effects of calculational uncertainties , 2008, Physics in medicine and biology.
[43] H. O. Wyckoff,et al. The International Commission on Radiation Units and Measurements , 2001, Journal of the ICRU.
[44] Y. Shibamoto,et al. Long-Term Outcome of Proton Therapy and Carbon-Ion Therapy for Large (T2a–T2bN0M0) Non–Small-Cell Lung Cancer , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[45] P. Smith. No-fly zone. , 2014 .
[46] Joe Y. Chang,et al. Therapy-Resistant Cancer Stem Cells Have Differing Sensitivity to Photon versus Proton Beam Radiation , 2013, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.
[47] Joe Y. Chang,et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a "no fly zone". , 2014, International journal of radiation oncology, biology, physics.